Percutaneous left atrial appendage closure

Area of Science:

• Cardiology
• Medical Devices
• Vascular Medicine

Background:

• Atrial fibrillation is a major risk factor for stroke due to cardiac embolism.
• Oral anticoagulation is the standard therapy for preventing these embolic events.
• However, oral anticoagulation is contraindicated in some patients, particularly those with a history of serious bleeding.

Purpose of the Study:

• To review the physiology and pathophysiology of the left atrial appendage.
• To discuss percutaneous left atrial appendage closure as an alternative stroke prevention strategy.
• To outline the indications and scientific rationale for left atrial appendage closure devices.

Main Methods:

• Literature review of studies on atrial fibrillation, stroke, anticoagulation, and left atrial appendage closure.
• Analysis of the anatomical and physiological aspects of the left atrial appendage.
• Evaluation of existing percutaneous left atrial appendage closure devices and their clinical evidence.

Main Results:

• The left atrial appendage is a primary source of thrombus formation in atrial fibrillation.
• Percutaneous left atrial appendage closure devices effectively exclude the appendage, reducing embolism risk.
• Various devices are available, each with specific implantation techniques and patient selection criteria.

Conclusions:

• Percutaneous left atrial appendage closure is a viable alternative to oral anticoagulation for stroke prevention in high-risk atrial fibrillation patients.
• Careful patient selection based on bleeding risk and anatomical suitability is crucial for successful outcomes.
• Continued research and device development are expanding the role of left atrial appendage closure in managing atrial fibrillation-related stroke risk.